TY  - GEN
AU  - Lau,G K K
AU  - Nanji,A
AU  - Hou,J
AU  - Fong,D Y T
AU  - Au,W-S
AU  - Yuen,S-T
AU  - Lin,M
AU  - Kung,H-F
AU  - Lam,S-K
TI  - Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase
SN  - 1352-0504
PY  - 2002///1017
KW  - 2-Aminopurine
KW  - analogs & derivatives
KW  - Adjuvants, Immunologic
KW  - therapeutic use
KW  - Adolescent
KW  - Adult
KW  - Antiviral Agents
KW  - Cell Division
KW  - Cells, Cultured
KW  - Cytokines
KW  - biosynthesis
KW  - DNA, Viral
KW  - blood
KW  - Drug Therapy, Combination
KW  - Famciclovir
KW  - Female
KW  - Hepatitis B Core Antigens
KW  - immunology
KW  - Hepatitis B Surface Antigens
KW  - Hepatitis B e Antigens
KW  - Hepatitis B virus
KW  - genetics
KW  - Hepatitis B, Chronic
KW  - Humans
KW  - Immune Tolerance
KW  - Male
KW  - Middle Aged
KW  - T-Lymphocytes
KW  - drug effects
KW  - Thymalfasin
KW  - Thymosin
KW  - Time Factors
N1  - Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1046/j.1365-2893.2002.00361.x
ER  -